# A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

> **NCT02077946** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 1059 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide
- **DRUG:** sitagliptin

## Key facts

- **NCT ID:** NCT02077946
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-10
- **Primary completion:** 2014-09-03
- **Final completion:** 2014-09-03
- **Target enrollment:** 1059 (ACTUAL)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02077946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02077946, "A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02077946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*